Medtronic has announced that its Hugo Robot-Assisted Surgery (RAS) system was used for the first time to perform a commercial procedure at the Cleveland Clinic. This historic milestone follows the system’s regulatory clearance.
The procedure, a robot-assisted prostatectomy, was successfully performed by Dr. Jihad Kaouk, Professor and Chair at the Glickman Urological Institute. According to Medtronic, the patient was discharged the day after surgery, highlighting positive early clinical outcomes.
What the Hugo System Adds to Surgery
The Hugo RAS system represents a next-generation robotic platform designed to expand access to minimally invasive surgery and provide surgeons with greater flexibility and control. Unlike traditional single-console robotic platforms, Hugo’s modular design and open surgical console aim to create a more organized operating room environment and foster better team collaboration.
Key features of the Hugo system include:
-
Modular Robotic Arms: These can be positioned around the operating table for optimal access.
-
Open, Upright Console: Helps surgeons reduce physical strain and improves situational awareness.
-
Integration with Touch Surgery™ Digital Ecosystem: Provides educational resources, AI-based analytics, and surgical video reviews to support continuous improvement and team coordination.
Growing Clinical Scale
The Hugo system received authorization in the United States for urological procedures, including prostatectomy, nephrectomy, and other soft tissue surgeries. This regulatory milestone is based on the FDA (U.S. Food and Drug Administration) clearance granted in late 2025. Medtronic is also continuing additional clinical trials for hernia repairs and gynecological procedures, signaling a future expansion of Hugo’s scope of use.
Significance for Surgery
Systems like Hugo represent a significant shift in the methodology of complex surgeries. By increasing precision, reducing surgical trauma, and supporting minimally invasive techniques, these platforms can improve patient outcomes and reduce rehabilitation time.
With the completion of the first commercial surgery in the U.S., Hugo enters a competitive environment previously dominated by other robotic systems. However, its new design philosophy and integrated digital tools signal a major evolution in surgical robotics.
In Georgia, Medtronic products are actively used, particularly in cardiac surgery and invasive cardiology—including artificial valves, stent grafts, pacemakers, and more. Unfortunately, at this stage, the company’s even more high-tech devices, such as robot-assisted systems, are not yet available in the country due to various obstacles. However, there is always hope that such technologies will be actively implemented in our country in the future.
Source: Medtronic
